Omeros (OMER) Cash & Equivalents (2010 - 2026)
Omeros' Cash & Equivalents came in at $1.99 million for Q2 2026, up 4.4% from $1.9 million a year earlier and up 4.3% from the prior quarter.
Powered by 
Analysis
Omeros (OMER) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Omeros' Cash & Equivalents was $9.66 million, up 184.1% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $3.4 million in FY2024 (-52.1%), $7.11 million in FY2023 (-35.5%), $11.01 million in FY2022 (-89.1%) and $100.81 million in FY2021 (+860.0%).
- The five-year range for quarterly Cash & Equivalents is $1.52 million (Q3 2024) to $145.53 million (Q3 2022).
- Year-over-year, Cash & Equivalents increased in four of the last eight quarters, with growth averaging 20.8%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2021 (growth of 860.0%), and the weakest in Q3 2024 (a decline of 95.0%).
- Business Quant data shows OMER's Cash & Equivalents at $1.91 million (Q1 2026), $9.66 million (Q4 2025) and $2.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Omeros | 1.34 Bn | 1.34 Bn | 27.73 Mn | 1.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.99 Mn |
| Mar 31, 2026 | 1.91 Mn |
| Dec 31, 2025 | 9.66 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 3.40 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 7.11 Mn |
| Sep 30, 2023 | 30.64 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 11.01 Mn |
| Sep 30, 2022 | 145.53 Mn |
| Jun 30, 2022 | 14.14 Mn |
| Mar 31, 2022 | 9.00 Mn |
| Dec 31, 2021 | 100.81 Mn |
| Sep 30, 2021 | 7.42 Mn |
API Access
Omeros Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OMER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OMER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OMER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();